Assessment of Donor‐Specific Human Leukocyte Antigen Antibodies Following Pediatric Liver Transplantation: Predictors, Protectors, and Clinical Relevance
Clinical Transplantation · 2025
DOI: 10.1111/ctr.70390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2025. Verfasst von Evelien Kanaan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics II, University Children's Hospital, Essen, Germany. Hauptthemen laut MEDLINE: Liver Transplantation, HLA Antigens, Graft Rejection, Isoantibodies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Following pediatric liver transplantation (pLT), the significance and management of donor‐specific antibodies (DSA) against human leukocyte antigen (HLA) remain undefined. The aim of this single‐center study was to investigate the occurrence of DSA, their clinical impact on predictors for and protectors against DSA. Patients and Methods We compared anti‐HLA DSA (cutoff for mean fluorescence intensity (MFI) ≥ 1000), clinical and laboratory results and outcome in a routine (RG, n = 142, standard DSA testing) and a hepatopathy group (HG, n = 19, DSA testing following indeterminate hepatopathy) in 161 pLT patients, treated 2000–2021, retrospectively.
Results
40% of RG and 32% of HG patients were DSA+ (39% of all patients, of which 13% with antibody‐mediated rejection [AMR]). Most frequent DSA subtypes were HLA‐DQ3, ‐DQ1, ‐DQ2 in RG and HLA‐DQ2, ‐DR15 in HG. MFI was higher for anti‐HLA II DSA (15 257 DSA+ vs. 5500 DSA−, p = 0.003), especially with AMR (21 000 DSA+ with AMR vs. 14 584 DSA+ without AMR, p = 0.042). Predictors for DSA included age at pLT, re‐pLT, and cystic fibrosis. Living donation and cold ischemia time
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics II, University Children's Hospital, Essen, Germany.
- Institute for Transfusion Medicine, Transplantation Diagnostic, University Hospital, Essen, Germany.
- Department of General, Visceral- and Transplant Surgery, University Hospital, Essen, Germany.
ORCID-Profile: Elke Lainka
Zitieren
APA
Kanaan, E., Ohlsson, S., Kathemann, S., Prusinskas, B., Tsaka, S., Heinemann, F. M., Heinold, A., Schulze, M., Pape, L., & Lainka, E. (2025). Assessment of Donor‐Specific Human Leukocyte Antigen Antibodies Following Pediatric Liver Transplantation: Predictors, Protectors, and Clinical Relevance. Clinical Transplantation. https://doi.org/10.1111/ctr.70390
Vancouver
Kanaan E, Ohlsson S, Kathemann S, Prusinskas B, Tsaka S, Heinemann FM, et al. Assessment of Donor‐Specific Human Leukocyte Antigen Antibodies Following Pediatric Liver Transplantation: Predictors, Protectors, and Clinical Relevance. Clinical Transplantation. 2025. doi:10.1111/ctr.70390
BibTeX
@article{Kanaan2025,
author = {Kanaan, Evelien and Ohlsson, Sinja and Kathemann, Simone and Prusinskas, Benas and Tsaka, Sofia and Heinemann, Falko M and Heinold, Andreas and Schulze, Maren and Pape, Lars and Lainka, Elke},
title = {Assessment of Donor‐Specific Human Leukocyte Antigen Antibodies Following Pediatric Liver Transplantation: Predictors, Protectors, and Clinical Relevance},
journal = {Clinical Transplantation},
year = {2025},
doi = {10.1111/ctr.70390}
}
EUVIMED